Lista de obras - G Racagni - Dominio Público Uruguay

Antidepressant Treatments Change 5-HT2C Receptor mRNA Expression in Rat Prefrontal/Frontal Cortex and Hippocampus

artículo científico publicado en 2011

Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels.

artículo científico publicado en 2011

Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions.

artículo científico publicado en 2005

Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress.

artículo científico publicado en 2004

Corticostriatal up-regulation of activity-regulated cytoskeletal-associated protein expression after repeated exposure to cocaine

artículo científico publicado en 2006

Dopaminergic D2 receptor activation modulates FGF-2 gene expression in rat prefrontal cortex and hippocampus

artículo científico publicado en 2003

Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants

artículo científico publicado en 2009

Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity

artículo científico publicado en 2003

Emerging role of the FGF system in psychiatric disorders

artículo científico publicado en 2005

Expression and phosphorylation of delta-CaM kinase II in cultured Alzheimer fibroblasts

artículo científico publicado en 2004

Genome-wide analysis of LPS-induced inflammatory response in the rat ventral hippocampus: Modulatory activity of the antidepressant agomelatine

artículo científico publicado en 2017

Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo[1,2,3-de]-1,4-benzo

artículo científico publicado en 2007

Long-term soluble Abeta1-40 activates CaM kinase II in organotypic hippocampal cultures.

artículo científico publicado en 2006

Prenatal stress elicits regionally selective changes in basal FGF-2 gene expression in adulthood and alters the adult response to acute or chronic stress.

artículo científico publicado en 2005

Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801.

artículo científico publicado en 2004

Reduction of corticostriatal glutamatergic fibers in basic fibroblast growth factor deficient mice is associated with hyperactivity and enhanced dopaminergic transmission.

artículo científico publicado en 2006

Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs

artículo científico publicado en 2006

Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades

artículo científico publicado en 2004

Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism

artículo científico publicado en 1997

Lista de obras de G Racagni

Antidepressant Treatments Change 5-HT2C Receptor mRNA Expression in Rat Prefrontal/Frontal Cortex and Hippocampus

Chronic antidepressant treatments induce a time-dependent up-regulation of AMPA receptor subunit protein levels.

Chronic treatment with fluoxetine up-regulates cellular BDNF mRNA expression in rat dopaminergic regions.

Corticostriatal brain-derived neurotrophic factor dysregulation in adult rats following prenatal stress.

Corticostriatal up-regulation of activity-regulated cytoskeletal-associated protein expression after repeated exposure to cocaine

Dopaminergic D2 receptor activation modulates FGF-2 gene expression in rat prefrontal cortex and hippocampus

Early raise of BDNF in hippocampus suggests induction of posttranscriptional mechanisms by antidepressants

Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity

Emerging role of the FGF system in psychiatric disorders

Expression and phosphorylation of delta-CaM kinase II in cultured Alzheimer fibroblasts

Genome-wide analysis of LPS-induced inflammatory response in the rat ventral hippocampus: Modulatory activity of the antidepressant agomelatine

Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo[1,2,3-de]-1,4-benzo

Long-term soluble Abeta1-40 activates CaM kinase II in organotypic hippocampal cultures.

Prenatal stress elicits regionally selective changes in basal FGF-2 gene expression in adulthood and alters the adult response to acute or chronic stress.

Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801.

Reduction of corticostriatal glutamatergic fibers in basic fibroblast growth factor deficient mice is associated with hyperactivity and enhanced dopaminergic transmission.

Regulation of editing and expression of glutamate alpha-amino-propionic-acid (AMPA)/kainate receptors by antidepressant drugs

Selective phosphorylation of nuclear CREB by fluoxetine is linked to activation of CaM kinase IV and MAP kinase cascades

Striatal increase of neurotrophic factors as a mechanism of nicotine protection in experimental parkinsonism